Table 2.

Comparison of clinical and MRD based risk groups in the study by Van Dongen and colleagues¹⁰

Clinical risk assessment			MRD based risk assessment
Risk group	% Of patients	3 year RFS (%)	Risk group	% Of patients	3 year RFS (%)
Standard	26	87	Low	42.5	98
Medium	64.5	80	Intermediate	42.5	77
High	9.5	30	High	15	25

MRD, minimal residual disease; RFS, recurrence free survival.